Nationwide survey on the treatment policy for well-differentiated thyroid cancer - Results of a questionnaire distributed at the 37th meeting of the Japanese society of thyroid surgery

Endocrine Journal

Volumn 52, Issue 4, 2005, Pages 479-491

  Shigematsu, Naoyuki ^a   Takami, Hiroshi ^b   Ito, Nobutake ^a   Kubo, Atsushi ^a  

^a KEIO UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

The Japanese Society of Thyroid Surgery; Treatment policy; Well differentiated thyroid cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; FEMALE; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; HUMAN TISSUE; JAPAN; MALE; MEDICAL SOCIETY; PHYSICIAN; QUESTIONNAIRE; THYROID CARCINOMA; THYROID SURGERY; TREATMENT PLANNING;

CARCINOMA, PAPILLARY; CELL DIFFERENTIATION; HEALTH CARE SURVEYS; HUMANS; JAPAN; NEOPLASM RECURRENCE, LOCAL; ORGANIZATIONAL POLICY; QUESTIONNAIRES; SOCIETIES, MEDICAL; THYROID NEOPLASMS; WESTERN WORLD;

EID: 25644439214     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.52.479     Document Type: Article

References (30)

1. Ematsu S, Itou K (2004) Meaning of mass screening for thyroid cancer using ultrasound and how to treat detected micro carcinoma. J Clin Surg 59: 395-399.
2. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK (2004) SEER Cancer Statistics Review, 1975-2001, National Cancer Institute. Bethesda, MD.
3. Martinez-Tello FJ, Martinez-Cabruja R, Fernandez-Martin J, Lasso-Oria C, Ballestin-Carcavilla C (1993) Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with different methods. Cancer 71: 4022-4029.
4. Neuhold N, Kaiser H, Kaserer K (2001) Latent carcinoma of the thyroid in Austria: a systemic autopsy study. Endocr Pathol 12: 23-31.
5. Avetisian IL, Petrova GV (1996) Latent thyroid pathology in residents of Kiev, Ukraine. J Environ Pathol Toxicol Oncol 15: 239-243.
6. Mitselou A, Vougiouklakis T, Peschos D, Dallas P, Agnantis NJ (2002) Occult thyroid carcinoma. A study of 160 autopsy cases. The first report for the region of Epirus-Greece. Anticancer Res 22: 427-432.
7. Fukunaga FH, Yatani R (1975) Geographic pathology of occult thyroid carcinomas. Cancer 36: 1095-1099.
8. Yamamoto Y, Maeda T, Izumi K, Otsuka H (1990) Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases. Cancer 65: 1173-1179.
9. Sherman SI (2003) Thyroid carcinoma. Lancet 361: 501-511.
10. Cady B, Rossi R (1998) An expanded view of risk group definition in differentiated thyroid carcinoma. Surgery 104: 947-953.
11. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS (1993) Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114: 1050-1057.
12. Hundahl SA, Cady B, Cunningham MP, Mazzaferri E, McKee RF, Rosai J, Shah JP, Fremgen AH, Stewart AK, Holzor S (2000) Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. Cancer 89: 202-217.
13. Cady B (1997) Our AMES is true; How an old concept still hit the mark: or, risk group assignment points the arrow to rational therapy selection in differentiated thyroid cancer. Am J Surg 174: 462-468.
14. Hay ID, Grant CS, Bergstralh EJ, Thompson CB, vanHeerden JA, Goellner JR (1998) Unilateral total lobectomy; Is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery 124: 958-966.
15. Okamoto T, Obara T (2004) Surgical management for papillary carcinoma of the thyroid. J Clin Surg 59: 405-408.
16. Noguchi S, Murakami N, Yamashita H, Toda M, Kawamoto H (1998) Papillary thyroid carcinoma; Modified neck dissection improves prognosis. Arch Surg 133: 276-280.
17. Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97: 418-428.
18. McGriff NJ, Csako G, Gourgiotis L, Lori CG, Pucino F, Sarlis NJ (2002) Effects of thyroid hormone suppression therapy of adverse clinical outcomes in thyroid cancer. Ann Med 34: 554-564.
19. Mazzaferri EL (1993) Management of a solitary thyroid nodule. N Engl J Med 328: 553-559.
20. Vickery AL, Wang C-A, Walker AM (1987) Treatment of intrathyroidal papillary carcinoma of the thyroid. Cancer 60: 2587-2595.
21. Faber J, Galloe AM (1994) Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment; a meta-analysis. Eur J Endocrinol 130: 350-356.
22. Forfar JC, Feek CM, Miller HC, Toft AD (1981) Atrial fibrillation and isolated suppression of the pituitary-thyroid axis; response to specific antithyroid therapy. Int J Cardiol 1:43-48.
23. Schelfhout LJDM, Creutzberg CL, Hamming JF, Fleuren GJ, Smeenk D, Hermans J, van de Velde CJ, Goslings BM (1998) Multivariate analysis of survival in differentiated thyroid cancer: the prognostic significance of the age factor. Eur J Cancer Clin Oncol 24: 331-337.
24. Hay ID (1990) Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 19: 545-576.
25. Pacini F, Lari R, Mazzeo S, Grasso L, Taddei D, Pinchera A (1985) Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer. Clin Endocrinol 23: 405-411.
26. Haugen B, Pacini F, Reiners C (1999) A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 84: 3877-3885.
27. Iwasaki H (2004) Surgical treatment for extra-thyroidal invasion of thyroid cancer. J Clin Surg 59: 419-423.
28. Sugino K, Asahara T (2004) Surgical management for recurrent well differentiated thyroid carcinoma. J Clin Surg 59: 425-430.
29. Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1998) A national cancer data base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 83: 2638-2648.
30. National Comprehensive Cancer Network: Thyroid carcinoma, Clinical Practice Guidelines in Oncology - version 1 (2004).